Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates

This publication has 33 references indexed in Scilit:

• Novel Conserved Genotypes Correspond to Antibiotic Resistance Phenotypes of E. coli Clinical Isolates
  PLOS ONE, 2013
• Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
  Applied Microbiology and Biotechnology, 2011
• Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance
  Nature Structural & Molecular Biology, 2010
• Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases
  PLOS ONE, 2010
• Current therapy of acute uncomplicated cystitis
  International Journal of Urology, 2010
• DNA topoisomerase II and its growing repertoire of biological functions
  Nature Reviews Cancer, 2009
• Contributions of the Combined Effects of Topoisomerase Mutations toward Fluoroquinolone Resistance in Escherichia coli
  Antimicrobial Agents and Chemotherapy, 2007
• Determination of the Primary Target of a Quinolone Drug and the Effect of Quinolone Resistance-Conferring Mutations by Measuring Quinolone Sensitivity Based on Its Mode of Action
  Antimicrobial Agents and Chemotherapy, 2007
• Structure, Molecular Mechanisms, and Evolutionary Relationships in DNA Topoisomerases
  Annual Review of Biophysics, 2004
• Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone‐resistant isolates
  Molecular Microbiology, 1994